NCT07055178

Brief Summary

The goal of this clinical trial is to learn if a virtual reality (VR) program (TRIPP) can reduce pain, anxiety, and distress in adult men (aged 18+) undergoing a vasectomy under local anesthesia. The main questions it aims to answer are:

  • Does using VR during a vasectomy lower patients' pain during the procedure compared to standard care?
  • Does VR reduce anxiety and distress compared to standard care?
  • Are patients more satisfied with their experience when using VR compared to standard care? Researchers will compare two groups:
  • VR group: Patients will use a VR headset with a guided meditation program (TRIPP) during their vasectomy.
  • Control group: Patients will receive standard care (no VR). Participants will:
  • Be randomly assigned to either the VR group or control group.
  • Complete brief questionnaires before, during, and after the procedure (about 15-20 minutes each time).
  • (VR group only) Use a VR headset during the procedure and provide optional feedback about the experience. Why is this important? Vasectomies are typically done with local anesthesia (pain relief), but many patients still feel anxiety or discomfort. VR may help distract and relax patients, improving their experience. This study will help health professionals understand if VR could be a useful option for future patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Jul 2025Aug 2026

First Submitted

Initial submission to the registry

June 13, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

July 2, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 8, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

May 5, 2026

Status Verified

July 1, 2025

Enrollment Period

1.1 years

First QC Date

June 13, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

Virtual RealityTRIPPVasectomy

Outcome Measures

Primary Outcomes (1)

  • Numeric Rating Scale (NRS) for Pain Severity

    During and immediately following the procedure, patients will be momentarily interrupted to give a brief NRS verbal response question measure of their level of acute pain, this is on a scale of 0-10; 10 = most severe pain.

    Perioperatively (midway through procedure) and immediately following the procedure.

Secondary Outcomes (8)

  • Numeric Rating Scale (NRS) for Discomfort Severity

    Perioperatively (midway through procedure) and immediately following the procedure.

  • Numeric Rating Scale (NRS) for Anxiety Severity

    Perioperatively (midway through procedure) and immediately following the procedure.

  • PROMIS Pain Intensity Scale Total Score

    Within 10 minutes postoperatively (in the recovery room)

  • State Trait Anxiety Inventory Total Score

    10 minutes preoperatively (baseline) and within 10 minutes postoperatively (in the recovery room.

  • National Comprehensive Cancer Network (NCCN) Anxiety Thermometer Score (adapted from Distress Thermometer)

    10 minutes preoperatively (baseline) and within 10 minutes postoperatively (in the recovery room.

  • +3 more secondary outcomes

Study Arms (2)

Standard Vasectomy

ACTIVE COMPARATOR

Vasectomy treatment as usual, with local anesthetic, without virtual reality.

Other: Treatment as usual

Virtual Reality Vasectomy

EXPERIMENTAL

This group of participants will receive undergo their vasectomy with the virtual reality intervention alongside the local anesthetic.

Device: Virtual reality (VR) guided meditation therapy

Interventions

Participants will engage in the TRIPP relaxation app on the MetaQuest 3 VR headset.

Virtual Reality Vasectomy

Participants undergo a standard vasectomy.

Standard Vasectomy

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older.
  • Can speak and read English.
  • Have elected for a vasectomy.
  • Are scheduled to undergo their vasectomy under local anesthesia at the Men's Health Clinic

You may not qualify if:

  • Those who are not competent to provide informed consent (e.g., due to cognitive impairment).
  • Those who are unable to participate in a VR intervention (e.g., due to visual or auditory impairment).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manitoba Men's Health Clinic

Winnipeg, Manitoba, R3P 2S8, Canada

RECRUITING

MeSH Terms

Conditions

PainAnxiety Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Renée El-Gabalawy, MA, PhD, C. Psych

    University of Manitoba

    PRINCIPAL INVESTIGATOR
  • Premal Patel, MD, FRCSC

    Manitoba Men's Health Clinic

    PRINCIPAL INVESTIGATOR
  • Ahmed M Zalam, B.Sc.

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Renée El-Gabalawy, MA, PhD, C.Psych.

CONTACT

Ahmed M Zalam, B.Sc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 13, 2025

First Posted

July 8, 2025

Study Start

July 2, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

May 5, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Study data and information from the study will not be sent outside of the University of Manitoba. Records containing health related information will be treated as confidential in accordance with Personal Health Information Act of Manitoba (PHIA). Information gathered in this research study may be published or presented in public forums, however names and other identifying personal information will not be revealed. Data will be coded and names will not be released.

Locations